Fig. 3From: Improved therapeutic consistency and efficacy of CD317+ MSCs through stabilizing TSG6 by PTX3Improved Therapeutic Effects of CD317+ MSCs. A PBMC proliferation assay after coculture with CD317+ or CD317− MSCs. B Body weight of IBD mice transplanted with CD317+ MSCs, CD317− MSCs, or negative control PBS (n = 8). C DAI (disease activity index) of IBD mice transplanted with CD317+ MSCs, CD317− MSCs, or negative control PBS (n = 8). D Representative figures of colon length. E Colon length of IBD mice transplanted with CD317+ MSCs, CD317− MSCs, or negative control PBS (n = 8). F Representative figures of HE staining of colon tissues after 10 days post DSS stimulation. G Histology score of IBD mice transplanted with CD317+ MSCs, CD317− MSCs, or negative control PBS (n = 8). *Indicates P < 0.05Back to article page